Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB (Oncotarget (2016) 7 (39796-39808) DOI: 10.18632/oncotarget.92900)

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

This article has been corrected: Due to errors during data processing, partial duplication occurred between Figures 2c, 2e and 4b. In addition, typing errors were made within Figure 6e and Supplemental 4a. In Figure 6e, the correlation coefficient (r value) in the picture is -0.177. In the original picture, the '-' is missing. In Supplementary figure 4a, the labeling of BECN-1 and EHMT2 were reversed. The authors declare that these corrections do not change the results or conclusions of this paper. (Figure Presented).

Cite

CITATION STYLE

APA

Park, S. E., Yi, H. J., Suh, N., Park, Y. Y., Koh, J. Y., Jeong, S. Y., … Hwang, J. J. (2019). Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB (Oncotarget (2016) 7 (39796-39808) DOI: 10.18632/oncotarget.92900). Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.27046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free